Clinical trial

Baclofen Versus Gabapentin in Preventing Postoperative Pain After Laparoscopic Sleeve

Name
35648
Description
The aim of this study is to compare the possible efficacy of baclofen and gabapentin on postoperative pain in patient with morbid obesity who will undergo laparoscopic sleeve gastrectomy.
Trial arms
Trial start
2023-06-30
Estimated PCD
2024-08-01
Trial end
2024-09-01
Status
Recruiting
Phase
Early phase I
Treatment
Baclofen 10mg
which will include 50 patients scheduled for sleeve gastrectomy and will receive 10 mg oral baclofen 1 h before anesthesia.
Arms:
Group 1 (baclofen)
Gabapentin
which include 50 patients scheduled for sleeve gastrectomy and will receive 600 mg oral gabapentin 1 h before anesthesia.
Arms:
Group 2 (gabapentin)
Size
100
Primary endpoint
visual analog scale (VAS) score
The first 48 hours after surgery.
Eligibility criteria
Inclusion Criteria: * - Age between 18-60 years old. * Both male and female patients will be included. * Morbidly obese patients scheduled for sleeve gastrectomy with BMI ≥35 kg/m2 with the presence of comorbidity such as hypertension, arthritis, and diabetes. * Morbidly obese patients scheduled for sleeve gastrectomy with BMI ≥ 40 kg/m2 without comorbidity. * Patients fit for anesthesia and surgery. Exclusion Criteria: * Patients with BMI \>55 kg/m2. * Patients with previous procedures for the treatment of obesity. * Pregnant females and lactating women. * Patients with psychological or psychiatric disease * Administration of antiemetic medication or systemic corticosteroids within 24 hours before surgery * Patients who experienced vomiting within 24 hours before surgery. * Patients with history of alcohol or drug abuse. * Patients with hypersensitivity or contraindications to any of the drugs used in this study.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE3'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'PREVENTION', 'maskingInfo': {'masking': 'TRIPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR']}}, 'enrollmentInfo': {'count': 100, 'type': 'ESTIMATED'}}
Updated at
2023-11-22

1 organization

2 products

1 indication

Organization
Tanta University
Product
Baclofen
Product
Gabapentin